NCT02931630
- Conditions
- Abdominal Obesity, Body Weight, Cardiovascular Disease, +18 more
- Locations
-
- Aarhus University Hospital, Dep. of clinical nutrition research Aarhus, Denmark
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,005 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
A Study to Test How SB756050 Affects Subjects With Type 2 Diabetes Mellitus After 6 Days of Dosing.
NCT00733577
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Hackensack, New Jersey, United States
- GSK Investigational Site San Antonio, Texas, United States
NCT02459353
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Seoul St.Mary's Hospital Seoul, South Korea
NCT01332071
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Goiânia, Goiás, Brazil
Completed
Get In Touch Phase 2
NCT03124043
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
NCT02007278
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Novartis Investigative Site Medellín, Antioquia, Colombia
- Novartis Investigative Site Manizales, Caldas Department, Colombia
- Novartis Investigative Site Cali, Colombia
- Novartis Investigative Site Bogotá, Cundinamarca, Colombia
NCT01589653
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Alexandria, Egypt
- Novo Nordisk Investigational Site Banī Suwayf, Egypt
- Novo Nordisk Investigational Site Cairo, Egypt
- Novo Nordisk Investigational Site Bandung, Indonesia
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Encinitas, California, United States
- Newport Beach, California, United States
Completed
A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
NCT00823940
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States
NCT01294553
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified